Cat. #153245
Anti-CEACAM19 [Z5P2D9*A9]
Cat. #: 153245
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 10-12 weeks
Target: Carcinoembryonic Antigen Related Cell Adhesion Molecule 19
Class: Monoclonal
Application: ELISA ; WB
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Ayham Alnabulsi
Institute: Vertebrate Antibodies Limited
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-CEACAM19 [Z5P2D9*A9]
- Alternate name: CEACAM19, CEA related cell adhesion molecule 19, CEAL1
- Cancer: Digestive / Gastrointestinal cancer
- Cancers detailed: Broadly Applicable;Intestinal
- Research fields: Apoptosis and autophagy;Cancer;Cell biology
- Clone: Z5P2D9*A9
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Strain: Balb/c
- Reactivity: Human
- Host: Mouse
- Application: ELISA ; WB
- Description: CEACAM19 belongs to the carcinoembryonic antigen (CEA) gene family. In humans, this family of proteins are involved in several key biological processes such as cell adhesion, cell growth and differentiation, cellular recognition, apoptosis and angiogenesis. Recent studies have shown that CEACAM19 is upregulated, at the mRNA level, in ovarian and breast cancer.
- Immunogen: Peptide sequence RSINPARPLP (BLAST analysis revealed 100% identity with Gorilla)
- Isotype: IgG
- Myeloma used: P3X63Ag8.653
- Recommended controls: ELISA- Peptide immunogen, Western Blot- CEACAM19 overexpression lysates
Target Details
- Target: Carcinoembryonic Antigen Related Cell Adhesion Molecule 19
- Tissue cell line specificity: ELISA- Peptide immunogen, Western Blot- CEACAM19 overexpression lysates
- Target background: CEACAM19 belongs to the carcinoembryonic antigen (CEA) gene family. In humans, this family of proteins are involved in several key biological processes such as cell adhesion, cell growth and differentiation, cellular recognition, apoptosis and angiogenesis. Recent studies have shown that CEACAM19 is upregulated, at the mRNA level, in ovarian and breast cancer.
Applications
- Application: ELISA ; WB
Handling
- Format: Liquid
- Concentration: 0.9-1.1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Shipping at 4° C